These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2031940)

  • 1. Localization and regulation of epidermal 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by barrier requirements.
    Proksch E; Elias PM; Feingold KR
    Biochim Biophys Acta; 1991 Apr; 1083(1):71-9. PubMed ID: 2031940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements.
    Proksch E; Elias PM; Feingold KR
    J Clin Invest; 1990 Mar; 85(3):874-82. PubMed ID: 2312730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis.
    Proksch E; Feingold KR; Elias PM
    J Invest Dermatol; 1992 Aug; 99(2):216-20. PubMed ID: 1629633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cutaneous permeability barrier disruption on HMG-CoA reductase, LDL receptor, and apolipoprotein E mRNA levels in the epidermis of hairless mice.
    Jackson SM; Wood LC; Lauer S; Taylor JM; Cooper AD; Elias PM; Feingold KR
    J Lipid Res; 1992 Sep; 33(9):1307-14. PubMed ID: 1402399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis.
    Harris IR; Farrell AM; Grunfeld C; Holleran WM; Elias PM; Feingold KR
    J Invest Dermatol; 1997 Dec; 109(6):783-7. PubMed ID: 9406821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The epidermis as metabolically active tissue: regulation of lipid synthesis by the barrier function].
    Proksch E
    Z Hautkr; 1990 Mar; 65(3):296-300. PubMed ID: 2187311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of the epidermal permeability barrier by lipids and hyperproliferation].
    Proksch E
    Hautarzt; 1992 Jun; 43(6):331-8. PubMed ID: 1628964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    Menon GK; Feingold KR; Mao-Qiang M; Schaude M; Elias PM
    J Invest Dermatol; 1992 Feb; 98(2):209-19. PubMed ID: 1732385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrier function regulates epidermal lipid and DNA synthesis.
    Proksch E; Holleran WM; Menon GK; Elias PM; Feingold KR
    Br J Dermatol; 1993 May; 128(5):473-82. PubMed ID: 8504036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical mevalonic acid stimulates de novo cholesterol synthesis and epidermal permeability barrier homeostasis in aged mice.
    Haratake A; Ikenaga K; Katoh N; Uchiwa H; Hirano S; Yasuno H
    J Invest Dermatol; 2000 Feb; 114(2):247-52. PubMed ID: 10651982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function.
    Kim M; Jung M; Hong SP; Jeon H; Kim MJ; Cho MY; Lee SH; Man MQ; Elias PM; Choi EH
    Exp Dermatol; 2010 Jun; 19(6):501-10. PubMed ID: 19703225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements.
    Holleran WM; Gao WN; Feingold KR; Elias PM
    Arch Dermatol Res; 1995; 287(3-4):254-8. PubMed ID: 7598529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice.
    Ottey KA; Wood LC; Grunfeld C; Elias PM; Feingold KR
    J Invest Dermatol; 1995 Mar; 104(3):401-4. PubMed ID: 7861009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice.
    Ghadially R; Brown BE; Hanley K; Reed JT; Feingold KR; Elias PM
    J Invest Dermatol; 1996 May; 106(5):1064-9. PubMed ID: 8618040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
    Schuler LA; Toaff ME; Strauss JF
    Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of epidermal lipid synthesis by permeability barrier requirements.
    Feingold KR
    Crit Rev Ther Drug Carrier Syst; 1991; 8(3):193-210. PubMed ID: 1954650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feeding.
    Wu N; Sarna LK; Hwang SY; Zhu Q; Wang P; Siow YL; O K
    Biochim Biophys Acta; 2013 Oct; 1832(10):1560-8. PubMed ID: 23651731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in zones of the adrenal cortex.
    Kubo M; Strott CA
    Endocrinology; 1987 Jan; 120(1):214-21. PubMed ID: 3023027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia.
    Feingold KR; Man MQ; Proksch E; Menon GK; Brown BE; Elias PM
    J Invest Dermatol; 1991 Feb; 96(2):201-9. PubMed ID: 1991980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in serum and bile cholesterol and HMG-CoA reductase by lovastatin in rats.
    Yamauchi S; Linscheer WG; Beach DH
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G625-30. PubMed ID: 2018137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.